AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT
Guides | 2014 | Agilent TechnologiesInstrumentation
HPLC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsqbd, method, development, dissolution, quality, design, critical, analytical, agilent, iset, attributes, principles, risk, variability, impurity, dad, space, mau, drug, impurities, assessment, methods, qualification, emulation, eliminating, multivariate, variables, cqas, elemental, evaluation, strategy, robust, quaternary, dimension, instrument, icp, system, control, define, mobile, api, profile, testing, analysis, binary, based, product, linagliptin, cmps, performance
Similar PDF
ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT
2014|Agilent Technologies|Brochures and specifications
ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT ENSURE QUALITY WITH RISK ASSESSMENT Agilent Solutions Help You Evaluate CQAs Critical quality attributes for drug substances typically include those properties or characteristics that affect identity, purity, biological activity, and stability.…
Key words
qbd, qbdagilent, agilentemulation, emulationmixing, mixingquality, qualityansfer, ansfervariability, variabilityonline, onlineintelligent, intelligenteliminate, eliminatedevelopment, developmentmetho, methoautomated, automatedconsistency, consistencyacquity
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology
2015|Agilent Technologies|Applications
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology Application Note Pharmaceutical QA/QC Author Abstract Vinayak A.K In this Application Note, a method was developed…
Key words
qbd, qbdmethod, methodhplc, hplccmps, cmpsdesign, designspace, spaceuhplc, uhplccmas, cmaspars, parsfusion, fusioncma, cmaoptimization, optimizationstrong, strongagilent, agilenttransferred
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
2017|Agilent Technologies|Applications
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application Note Pharmaceutical Developments and QA/QC Authors Abstract Vinayak A.K and Andreas Tei This…
Key words
qbd, qbdimp, impmethod, methodiset, isetuhplc, uhplcapi, apiemulation, emulationmin, minzorbax, zorbaximpurity, impurityhplc, hplcamlodipine, amlodipinetime, timefusion, fusionagilent
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product
2014|Agilent Technologies|Applications
Quality-by-Design Approach to Stability Indicating Method Development for Linagliptin Drug Product Application Note Pharmaceutical QA/QC Authors Abstract Syed Salman Lateef and Vinayak AK A traditional approach to method development could fail to meet desired Agilent Technologies, Inc. separation during validation,…
Key words
method, methodvariables, variablesfusion, fusionlinagliptin, linagliptinqbd, qbddesign, designdevelopment, developmentdoe, doegradient, gradientphase, phaseparameters, parametersmodeled, modeledindicating, indicatingapi, apiquality